Navigation Links
Hospira Expands Board of Directors
Date:8/17/2011

LAKE FOREST, Ill., Aug. 17, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that William G. Dempsey has been elected to the company's board of directors. Dempsey brings strong executive management and diverse global experience from leadership positions held in the healthcare industry. The addition of Dempsey expands Hospira's board to 11 directors, nine of whom are independent.

(Logo:  http://photos.prnewswire.com/prnh/20040503/HSPLOGO)

"Bill understands how to successfully grow a large, multinational healthcare business," said Christopher B. Begley, executive chairman. "His impressive track record of results-oriented leadership and operational experience in the healthcare field makes him an excellent fit for the Hospira board."

John C. Staley, Hospira's lead director, added, "We are excited to welcome Bill to Hospira's board of directors. His broad and deep knowledge of global healthcare markets enhances our current board membership and supports Hospira's goals for international expansion."

Dempsey, 59, spent more than two decades at Abbott Laboratories, most recently serving as executive vice president, Global Pharmaceuticals, where he was responsible for the company's $14 billion global pharmaceutical business, representing more than 33,000 employees. In this position, from which he retired in 2007, he drove the business to 15 percent growth in revenues and profitability in the face of major new generic competition. He also led an initiative that doubled research and development productivity over three years, and negotiated and integrated the successful $3.7 billion acquisition of the cardiovascular company, Kos Pharmaceuticals.

From 2003 to 2006, Dempsey was Abbott's senior vice presiden
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
2. Hospira Reports Second-Quarter 2011 Results
3. Hospira to Host Conference Call for Second-Quarter 2011 Results
4. Hospira Receives Health Canada Regulatory Approval for Symbiq™ Infusion System Software Upgrade
5. Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011
6. Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
7. Hospira Reports First-Quarter 2011 Results
8. Hospira Board Authorizes $1 Billion Share Repurchase Program
9. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
10. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
11. Hospira to Host Conference Call for First-Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... -- Mettler-Toledo International Inc. (NYSE: MTD ) today ... the highlights: , Sales in local currency ... year. Reported sales decreased 4% as currency reduced sales ... earnings per diluted share as reported (EPS) were $2.73, ... was $2.80 , an increase of 9% over ...
(Date:7/30/2015)... DIEGO , July 30, 2015  Tandem ... medical device company and manufacturer of the t:slim® ... has entered into non-exclusive Development Agreements with Dexcom, ... Tandem insulin pumps with the Dexcom G5 and ... "Integrating Tandem,s next generation pump platform with Dexcom,s ...
(Date:7/30/2015)... VANCOUVER , July 30, 2015 /PRNewswire/ ... that it will report its second quarter 2015 financial ... host a conference call and live webcast at 4:30 ... results, clinical development programs and a general corporate update. ... to the Investor Relations page of the OncoGenex website ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... BEIJING, Aug. 4, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, ... leading China-based advanced in-vitro diagnostic ("IVD") company, today announced ... the first fiscal quarter ended June 30, 2011 ("1Q ... 2011. The Company,s senior management will host ...
... N.J., Aug. 4, 2011 Omthera Pharmaceuticals, Inc., ... that Christian S. Schade will join the Company ... President and Chief Financial Officer, beginning in early ... experience as a public company financial executive in ...
Cached Medicine Technology:China Medical Technologies to Announce Results for the First Fiscal Quarter Ended June 30, 2011 on August 16, 2011 2Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer 2Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer 3
(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source of ... three new Board Exam Courses. , The additions of Gastroenterology, Pulmonology and Allergy/Immunology ... from MDLinx makes preparing for the exam easy and painless. MDLinx offers thousands ...
(Date:7/31/2015)... York (PRWEB) , ... July ... ... attorney Jason T. Brown’s live lecture on pharmaceutical negligence is now available ... 2015 was well received with a 94% approval rating from the nationwide ...
(Date:7/31/2015)... ... July 31, 2015 , ... Creating one of the most ... pursuit of a visionary image that goes beyond the boundaries of fertility medicine. ... has reached extraordinary heights with dependable patient support, affordable treatments, unending hope, and high ...
(Date:7/31/2015)... ... ... The 2015 ALS Ice Bucket Challenge will officially get underway today at ... Ice Bucket co-founders Pat Quinn and Pete Frates, the ALS community and Lou Gehrig’s ... the ALS organizations to find treatments and cures for the disease. , ALS ...
(Date:7/31/2015)... ... July 31, 2015 , ... The Heart Fit Clinic has increased ... until a heart rate of 150 beats versus 100 beats, this is a big ... able to give life back to patients with heart disease," he adds. People with ...
Breaking Medicine News(10 mins):Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 4Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... N.C., March 31 New research that delivers timely ... commercialization is now available in the Best Practice Database, ... firm Best Practices, LLC.To review sample key findings and ... page with links to each of the two new ...
... the company that is expected to become public from ... businesses, today filed a Form 10 registration statement with ... information about the company as a standalone entity. ... spin off at least 80 percent of the outstanding ...
... has come together to launch an important new type ... patients benefit as quickly as possible from cutting-edge research. ... be a held in Brussels from May 7-9, scientists ... who will implement their results will discuss how to ...
... Motion, Supporting Need for the CyberKnife System,s Real-Time Tracking ... /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ... of radiosurgery, announced today publication of the results from ... cancer, which was published in the March ...
... to 79 Have Experienced a Life Crisis Such ... or Major Illness or DisabilityWomen Significantly More Likely ... Inc. President Says Understanding Emotions, Getting Expert Advice ... a Life CrisisAARP Financial Inc. Offers Life Crisis ...
... for babies conceived in spring, summer, when chemical concentrations ... may increase the risk of birth defects, say researchers ... in U.S. babies occur among those conceived in the ... increased levels of pesticides in surface water. , Researchers ...
Cached Medicine News:Health News:Best Practice Database Adds Research Highlighting the Value of Portfolio Management in Early-Stage Commercialization and Customer-Focused Software Quality Assurance 2Health News:CareFusion Corporation Files Form 10 Registration Statement 2Health News:CareFusion Corporation Files Form 10 Registration Statement 3Health News:CareFusion Corporation Files Form 10 Registration Statement 4Health News:CareFusion Corporation Files Form 10 Registration Statement 5Health News:CareFusion Corporation Files Form 10 Registration Statement 6Health News:IMPAKT Breast Cancer Conference 2Health News:Stanford Study on CyberKnife Radiosurgery for Prostate Cancer Demonstrates 100 Percent PSA Response at 33 months 2Health News:Stanford Study on CyberKnife Radiosurgery for Prostate Cancer Demonstrates 100 Percent PSA Response at 33 months 3Health News:Stanford Study on CyberKnife Radiosurgery for Prostate Cancer Demonstrates 100 Percent PSA Response at 33 months 4Health News:Stanford Study on CyberKnife Radiosurgery for Prostate Cancer Demonstrates 100 Percent PSA Response at 33 months 5Health News:AARP Financial Inc. Survey Finds: Vast Majority of Families Struggle With Financial Implications of a Life Crisis 2Health News:AARP Financial Inc. Survey Finds: Vast Majority of Families Struggle With Financial Implications of a Life Crisis 3Health News:AARP Financial Inc. Survey Finds: Vast Majority of Families Struggle With Financial Implications of a Life Crisis 4Health News:AARP Financial Inc. Survey Finds: Vast Majority of Families Struggle With Financial Implications of a Life Crisis 5Health News:AARP Financial Inc. Survey Finds: Vast Majority of Families Struggle With Financial Implications of a Life Crisis 6Health News:AARP Financial Inc. Survey Finds: Vast Majority of Families Struggle With Financial Implications of a Life Crisis 7Health News:Study Links Pesticides to Birth Defects 2
Indications For Usage: , Emergency use. , When medicant during ventilation is required. ...
... Indications For Usage: ... ,The monitoring lumen is ... of tracheal gases especially end-tidal ... pressure. , Introducing medication. ...
Indications For Usage: ,Laser surgery of the larynx or other areas in close proximity to the tracheal tube using CO2 or KTP laser beam....
Indications For Usage: ,Airway management during pediatric surgical procedures and intensive care....
Medicine Products: